FDA Import Refusal AEK-9232477-8/21/1 — GSK
The FDA refused shipment AEK-9232477-8/21/1 from GSK (India) on Jun 30, 2021. The refused product falls under Drugs and Biologics — DAPSONE (ANTI-BACTERIAL). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Jun 30, 2021
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61HCY14 DAPSONE (ANTI-BACTERIAL)
- Charges
- 75